Walleye Capital
FLNA

Walleye Capital’s Filana Therapeutics FLNA Stock Holding History

Walleye Capital’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,000
Closed -$589K – 5469
2024
Q3 		$589K Buy
+20,000
New +$461K ﹤0.01% 3144
2023
Q3 		– Sell
-5,600
Closed -$137K – 5274
2023
Q2 		$137K Buy
+5,600
New +$135K ﹤0.01% 3297

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Walleye Capital's FLNA Position: Q4 2024 in Review

Walleye Capital sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 2,985 shares — an estimated $87.8K sold.

Walleye Capital first reported a position in FLNA in Q2 2023 and held it in 2 quarters. The position peaked at $136K in Q2 2023. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Walleye Capital reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Walleye Capital sold 2,985 Filana Therapeutics shares in Q4 2024, an estimated $87.8K.
  • Walleye Capital first reported a position in Filana Therapeutics in Q2 2023 and held it in 2 quarters.
  • Walleye Capital's Filana Therapeutics position peaked at $136K in Q2 2023.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Walleye Capital's 13F filing for Q4 2024, filed 13 Feb 2025.